KRMD Christopher Pazdan bought KORU Medical Systems, Inc. shares — SEC Form 4BUYKORU Medical Systems, Inc.

KRMD is trading 41.96% below its 52-week high of $6.608 and has declined 17.88% over the last 90 days, currently sitting at $3.835.

• •The purchase itself is the largest insider buy in the company's history.
• •Upcoming Q1 2026 earnings call on May 7, 2026, where the company reported a record start to the year with revenue up 22%.
• •EU MDR certification for the Freedom60 Infusion Pump secured on March 17, 2026, which opens broader EU access.

• •The stock trades at a high forward P/E of 52.5, which may be difficult to justify given the company's current unprofitability.
• •Short interest is low at 1.6% of the float, limiting potential short-covering support.